ACCC Clears Kimberly-Clark's Kenvue Deal, But Forces Sale of Carefree and Stayfree
KVUE sits 34% above its 52-week low of $14.02.
Summary
Australia's competition regulator approved Kimberly-Clark's acquisition of Kenvue, but only if the combined company divests the Carefree and Stayfree feminine care brands in Australia. The ACCC found that without the divestiture, the deal would substantially lessen competition in period care products. This is a key regulatory milestone for the merger, which was confirmed in Kenvue's Q2 earnings and is expected to close later this year. The divestiture requirement is a manageable condition and removes a major antitrust hurdle in Australia. Investors should watch for similar regulatory decisions in other jurisdictions as the deal progresses toward completion.
At the time of this announcement, KVUE was trading at $18.84 on NYSE in the Trade & Services sector, with a market capitalization of approximately $36B. The 52-week trading range was $14.02 to $20.82. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.